See All Slides - tctmd.com

Slides

Presentation TCT 2017

Synthesis of Randomized Trial and Registry Data for Devices in Cardiogenic Shock: What Is the Evidence for Efficacy?

Presenter: Vladimir Dzavik, Navin K. Kapur, Nicolas M. Van Mieghem

October 31, 2017

Presentation TCT 2017

CMS Strategy and the Move to Value

Presenter: Peter L Duffy, Hadley Wilson, John A. Spertus

October 31, 2017

Presentation TCT 2017

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

Presenter: Martin B. Leon, Changfu Wu

October 31, 2017

Presentation TCT 2017

Established TMVR 1: Cardiaq - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, James B. Hermiller Jr.

October 31, 2017

Presentation TCT 2017

Outcomes and Clinical Implications From the Euro-CTO Trial

Presenter: Barry D. Rutherford, Robert W. Yeh, Gerald S. Werner

October 31, 2017

Presentation TCT 2017

Trans-septal Puncture for LAA Closure Using Fluoroscopic Guidance

Presenter: Stefan C. Bertog, Apostolos Tzikas, Randall J. Lee

October 31, 2017

Presentation TCT 2017

Use of NCDR Registries to Evaluate Race and Gender Issues Related to Medications and Devices

Presenter: Alice K. Jacobs, Spencer B. King III, John C. Messenger

October 31, 2017

Presentation TCT 2017

Ukraine Presents to Egypt: Complications During a CTO PCI

Presenter: Mohammad Al-Mutairi, Ahmed Magdy, Maxim Sokolov

October 31, 2017

Presentation TCT 2017

SAPIEN 3 Procedural Pearls (Including Optimal Sizing Algorithms)

Presenter: Susheel K. Kodali

October 31, 2017

Presentation TCT 2017

NOBLE: Core Findings Revisited and New Data

Presenter: Antonio Colombo, David E. Kandzari, Evald H. Christiansen

October 31, 2017

Advertisement

Slides

Synthesis of Randomized Trial and Registry Data for Devices in Cardiogenic Shock: What Is the Evidence for Efficacy?

CMS Strategy and the Move to Value

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

Established TMVR 1: Cardiaq - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Outcomes and Clinical Implications From the Euro-CTO Trial

Trans-septal Puncture for LAA Closure Using Fluoroscopic Guidance

Use of NCDR Registries to Evaluate Race and Gender Issues Related to Medications and Devices

Ukraine Presents to Egypt: Complications During a CTO PCI

SAPIEN 3 Procedural Pearls (Including Optimal Sizing Algorithms)

NOBLE: Core Findings Revisited and New Data

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content